Activation and Signaling Mechanism of the RET Tyrosine Kinase Receptor
Activation and Signaling Mechanism of the RET Tyrosine Kinase Receptor
批准号:
8527362
负责人:
Jennifer Marie Chow
金额:
$3.32万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-12 至 2017-09-11
关键词:
AddressBindingBiologicalBostonCancer EtiologyCell CommunicationCell Differentiation processCell LineCell ProliferationCell SurvivalCell physiologyCell surfaceCellsComplexCoupledCouplingDNA Sequence RearrangementDevelopmentDimerizationDistalDoseEndocrineEventFamilyFellowshipFlow CytometryFluorescence Resonance Energy TransferGDNF family receptor alpha 3GPI Membrane AnchorsGoalsGrowth FactorGrowth Factor ReceptorsHealthHumanImmuneKnowledgeLaboratoriesLeadLifeLigandsMalignant NeoplasmsMeasuresMethodsMicroscopicModelingMolecularMonitorNeoplasmsNeurogliaNeuronsOncogene DeregulationOutputParathyroid glandPathway interactionsPheochromocytomaPlayPostdoctoral FellowProcessProteinsProto-OncogenesReceptor ActivationReceptor Protein-Tyrosine KinasesReceptor SignalingRegulationReporterResearchResearch SupportResolutionRoleSignal PathwaySignal TransductionStaining methodStainsStimulusStructureSurfaceSystemTechniquesTestingTherapeuticTrainingTransfectionTyrosineUncertaintyUniversitiesVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2Workcancer therapycancer typecareerdimerglial cell-line derived neurotrophic factorgraduate studentimprovedin vivomedullary thyroid carcinomameetingsnephrogenesisneurotrophic factorneurturinnovelnovel strategiesparathyroid hyperplasiapersephinprofessorpublic health relevancereceptorreceptor functionresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This fellowship will support the research aims and training of a graduate student in the laboratory of Professor Adrian Whitty at Boston University. Many forms of cancer are caused by aberrant signaling of growth factor (GF) receptors. Consequently, achieving an improved understanding of GF receptor activation and function continues to give rise to improved approaches to cancer treatment. However, many basic questions about the molecular mechanisms of GF receptor activation and signaling remain unanswered. We propose to develop new methods for the quantitative mechanistic study of GF receptor signaling, using the multicomponent RE-arranged during Transfection (RET) receptor as a test case. RET is a receptor tyrosine kinase that is the receptor for the glial cell-line deried neurotrophic factor (GDNF) family of neurotrophins. Deregulation of RET signaling is causally involved in several types of cancer, including multiple endocrine neoplasias (MEN) 2A and -2B, medullary thyroid carcinoma, parathyroid hyperplasia, and phaeochromocytoma. We propose to characterize the molecular mechanisms of RET activation and signaling by pursuing following three aims: 1) genetically encoded fluorescence resonance energy transfer (FRET) constructs will be used to develop a reporter system for monitoring RET association events on the surface of live cells using flow cytometry. 2) The FRET reporter constructs developed in Aim 1, will be used to address key questions concerning the mechanism of RET activation on live cells. These questions include addressing the difficult and longstanding uncertainty concerning whether GF receptors function by ligand-induced receptor dimerization, or alternatively by causing a structural rearrangement within pre-associated receptor dimers or oligomers. 3) The mechanisms and impact of crosstalk between RET and vascular endothelial growth factor receptor 2 (VEGFR2) will be explored, to establish at what levels in RET signaling crosstalk occurs and how the effects on RET function depend on the level of VEGFR2 stimulation. Collectively, these three aims will establish new methods to elucidate mechanisms of GF receptor activation, and will establish the mechanisms and impact of crosstalk between two different families of GF receptors. This research will help the fellow achieve her career goal, which is to lead an academic research group that addresses important biological problems relating to human health. She plans to address these problems by working at the molecular, cellular and in vivo levels of systems complexity, employing primarily a hypothesis-driven and (where appropriate) a quantitative perspective. The training plan in her graduate work will enable her to focus on developing her knowledge and capabilities of molecular and cellular approaches, with the idea that she will go on to encompass in vivo techniques and perspectives through post doctoral study in a suitable laboratory. Working together, the candidate and her sponsor have developed a highly effective plan for how to achieve the training she will need to meet her long-term career objectives.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Activation and Signaling Mechanism of the RET Tyrosine Kinase Receptor
-
批准号:8738812
-
项目类别:
-
资助金额:$3.36万
-
财政年份:2013
-
负责人:Jennifer Marie Chow
-
依托单位:
Activation and Signaling Mechanism of the RET Tyrosine Kinase Receptor
-
批准号:8915645
-
项目类别:
-
资助金额:$3.41万
-
财政年份:2013
-
负责人:Jennifer Marie Chow
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: